Microbial translocation, immune activation, and HIV disease

Nichole Klatt, Nicholas T. Funderburg, Jason M. Brenchley

Research output: Contribution to journalReview article

176 Citations (Scopus)

Abstract

The advent of combination antiretroviral therapy (cART) has significantly improved the prognosis of human immunodeficiency virus (HIV)-infected individuals. However, individuals treated long-term with cART still manifest increased mortality compared to HIV-uninfected individuals. This increased mortality is closely associated with inflammation, which persists in cART-treated HIV-infected individuals despite levels of plasma viremia below detection limits. Chronic, pathological immune activation is a key factor in progression to acquired immunodeficiency syndrome (AIDS) in untreated HIV-infected individuals. One contributor to immune activation is microbial translocation, which occurs when microbial products traverse the tight epithelial barrier of the gastrointestinal tract. Here we review the mechanisms underlying microbial translocation and its role in contributing to immune activation and disease progression in HIV infection.

Original languageEnglish (US)
Pages (from-to)6-13
Number of pages8
JournalTrends in Microbiology
Volume21
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Virus Diseases
HIV
Mortality
Viremia
Immune System Diseases
Disease Progression
Limit of Detection
Gastrointestinal Tract
Acquired Immunodeficiency Syndrome
Therapeutics
Inflammation

Keywords

  • HIV
  • Immune activation
  • Microbial translocation
  • Mucosal immunity

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)
  • Infectious Diseases
  • Virology

Cite this

Microbial translocation, immune activation, and HIV disease. / Klatt, Nichole; Funderburg, Nicholas T.; Brenchley, Jason M.

In: Trends in Microbiology, Vol. 21, No. 1, 01.01.2013, p. 6-13.

Research output: Contribution to journalReview article

Klatt, Nichole ; Funderburg, Nicholas T. ; Brenchley, Jason M. / Microbial translocation, immune activation, and HIV disease. In: Trends in Microbiology. 2013 ; Vol. 21, No. 1. pp. 6-13.
@article{e20eea83a57c4bfb9c340fcf95e3c200,
title = "Microbial translocation, immune activation, and HIV disease",
abstract = "The advent of combination antiretroviral therapy (cART) has significantly improved the prognosis of human immunodeficiency virus (HIV)-infected individuals. However, individuals treated long-term with cART still manifest increased mortality compared to HIV-uninfected individuals. This increased mortality is closely associated with inflammation, which persists in cART-treated HIV-infected individuals despite levels of plasma viremia below detection limits. Chronic, pathological immune activation is a key factor in progression to acquired immunodeficiency syndrome (AIDS) in untreated HIV-infected individuals. One contributor to immune activation is microbial translocation, which occurs when microbial products traverse the tight epithelial barrier of the gastrointestinal tract. Here we review the mechanisms underlying microbial translocation and its role in contributing to immune activation and disease progression in HIV infection.",
keywords = "HIV, Immune activation, Microbial translocation, Mucosal immunity",
author = "Nichole Klatt and Funderburg, {Nicholas T.} and Brenchley, {Jason M.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.tim.2012.09.001",
language = "English (US)",
volume = "21",
pages = "6--13",
journal = "Trends in Microbiology",
issn = "0966-842X",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Microbial translocation, immune activation, and HIV disease

AU - Klatt, Nichole

AU - Funderburg, Nicholas T.

AU - Brenchley, Jason M.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - The advent of combination antiretroviral therapy (cART) has significantly improved the prognosis of human immunodeficiency virus (HIV)-infected individuals. However, individuals treated long-term with cART still manifest increased mortality compared to HIV-uninfected individuals. This increased mortality is closely associated with inflammation, which persists in cART-treated HIV-infected individuals despite levels of plasma viremia below detection limits. Chronic, pathological immune activation is a key factor in progression to acquired immunodeficiency syndrome (AIDS) in untreated HIV-infected individuals. One contributor to immune activation is microbial translocation, which occurs when microbial products traverse the tight epithelial barrier of the gastrointestinal tract. Here we review the mechanisms underlying microbial translocation and its role in contributing to immune activation and disease progression in HIV infection.

AB - The advent of combination antiretroviral therapy (cART) has significantly improved the prognosis of human immunodeficiency virus (HIV)-infected individuals. However, individuals treated long-term with cART still manifest increased mortality compared to HIV-uninfected individuals. This increased mortality is closely associated with inflammation, which persists in cART-treated HIV-infected individuals despite levels of plasma viremia below detection limits. Chronic, pathological immune activation is a key factor in progression to acquired immunodeficiency syndrome (AIDS) in untreated HIV-infected individuals. One contributor to immune activation is microbial translocation, which occurs when microbial products traverse the tight epithelial barrier of the gastrointestinal tract. Here we review the mechanisms underlying microbial translocation and its role in contributing to immune activation and disease progression in HIV infection.

KW - HIV

KW - Immune activation

KW - Microbial translocation

KW - Mucosal immunity

UR - http://www.scopus.com/inward/record.url?scp=84871703067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871703067&partnerID=8YFLogxK

U2 - 10.1016/j.tim.2012.09.001

DO - 10.1016/j.tim.2012.09.001

M3 - Review article

C2 - 23062765

AN - SCOPUS:84871703067

VL - 21

SP - 6

EP - 13

JO - Trends in Microbiology

JF - Trends in Microbiology

SN - 0966-842X

IS - 1

ER -